Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Apr 2, 2009


Proteros biostructures last week announced Dirk Ullmann has joined the company as chief scientific officer.

Ullmann will be responsible for developing the science base at the firm and for all ongoing client projects, the company said in a statement. Prior to joining Proteros, Ullmann was senior vice president for discovery biology for Evotec's service division.

New England Peptide this week said it named John Phipps to the newly created position of western region business development manager.

Phipps will be responsible for developing custom solutions for new customers. Prior to joining NEP, he was president of Biolink Solutions, which supplies customized bio-conjugation services to life science firms and hospital. Phipps also founded Global Peptide Services in 2001 and was its chief executive until 2007 when the company merged with Huntsville, Ala.-based Pi Proteomics.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.